Literature DB >> 192803

Leukocyte and lymphocyte cyclic AMP responses in atopic eczema.

C W Parker, S Kennedy, A Z Eisen.   

Abstract

Lymphocytes from subjects with mild and severe atopic eczema were compared with normal control subjects in regard to their cAMP (3';5'-cyclic adenosine monophosphate) responses to a variety of stimulatory agents. Individuals in the severe eczema group were shown to have a significant diminution in their unstimulated lymphocyte cAMP levels and absolute cAMP responses to 0.5 mM theophylline, 0.5 mM theophyline + 1 micronM epinephrine, 10 mM isoproternol, 1 mM isoproterenol, 10 mM salbutamol, and 3 micron M PGE1. Individuals with mild eczema had a reduced response to 0.5 mM theophylline. The severe eczema groups also differed in a number of these responses from a group of 5 subjects with severe psoriasis. Mixed leukocyte cAMP responses to 10 mM isoproterenol also were examined and found to be diminished in individuals with eczema.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192803     DOI: 10.1111/1523-1747.ep12494569

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Inhibition of IgE-mediated histamine release from human leukocytes by a new xanthine derivative, D 4026.

Authors:  B A Petersson; I Svedinger; K Bohlinder
Journal:  Agents Actions       Date:  1980-11

Review 2.  Pharmacophysiology of atopic dermatitis.

Authors:  J M Hanifin
Journal:  Clin Rev Allergy       Date:  1986-02

3.  Impaired monocyte-mediated cytotoxicity in atopic dermatitis.

Authors:  K Kragballe; T Herlin; J R Jensen
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

Review 4.  Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease.

Authors:  Domenico Spina
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.

Authors:  Anna B Fishbein; Jonathan I Silverberg; Eve J Wilson; Peck Y Ong
Journal:  J Allergy Clin Immunol Pract       Date:  2019-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.